Elevated Levels of Circulating γ‐Tocopherol as a Surrogate Marker of Mortality Risk in Populations of Adult Men Stratified by Health Index Score
Authors: Cooney Robert V. , Wagner Jared C. A. 
Published: November 2023

BackgroundPrevious research has demonstrated that circulating levels of γ‐tocopherol (γT) increase in response to nutrient deficiencies, poor diet, and conditions associated with increased risk of death. Because of its novel chemistry, its unique response to inflammation in vivo, and previously described relation to adherence to the DASH diet,* the utility of elevated levels of γT as a surrogate population‐level marker of mortality risk in men was investigated.ApproachA Health Index (HI) was developed utilizing seven physiological and demographic variables for which evidence of an association with poor health outcomes exists (Table 1). Levels considered to be healthy were assigned a value of one whereas values considered to be unhealthy were assigned a value of zero and intermediate levels a value of 0.5 (Table 1). Plasma values and demographic data from control subjects of a prostate cancer study described previously** (637 control men**; mean age at blood draw = 68.64 years) from the Multiethnic Cohort, for which there was no missing data, were used to determine a HI score (range from 0, unhealthy – 7, healthy) for each individual. The relation of the index score to mortality and γT was assessed by determining odds ratios for all‐cause mortality and hyper‐γ‐tocopherolemia (γT ≥2 μg/ml) for six stratified groups of men with HI scores varying from 0 to 7. Odds ratios and p values were calculated by two‐sided Fisher's exact test.ResultsAs shown in Table 2, individuals with the lowest HI scores (<2) were significantly more likely to die than those with HI scores >5 (OR = 7.00; p <0.0001) during the period of observation (median = 6.3 years). The group with the lowest HI score also had a significantly greater proportion of men found to be hyper‐γ‐tocopherolemic, OR = 6.92 (p< 0.0001). Intermediate HI scores were generally associated with intermediate odds for both death and hyper‐γ‐tocopherolemia. No significant differences in age were observed between groups in Table 2. Additional analysis of 317 matched subjects that subsequently developed prostate cancer in the same cohort study yielded similar results, consistent with the observations on the control subjects. Assessment of years lost/100 years of observation showed control men with HI scores of <3 lost 7.98 years/100 years observed compared to 2.03/100 in those scoring HI >5 (p<0.0001). Figure 1 shows the change in mean plasma γT as a function of HI score.ConclusionsHyper‐γ‐tocopherolemia may be a useful surrogate marker for comparing the risk of premature mortality between older male populations in cohort studies and for intervention trials designed to lower mortality risk. γT provides a population marker for which it is predicted that interventions which alter mortality risk may have a direct impact on circulating γT levels. Further studies utilizing larger populations, women, additional risk factors, and modifiable health behaviors are needed to verify the general utility of hyper‐γ‐tocopherolemia as a biomarker of a population's mortality risk.Support or Funding InformationThis work was supported in part by National Cancer Institute grantsR03 CA132149, P01 CA33619, R37 CA54281, S10 RR020890, and P30CA71789.
Selected parameters used to create a Health Index (HI) score.

Risk Factor
Values
Health Index Score

Smoking Status
Nonsmoker
1.0

Former
0.5

Current
0

BMI (kg/m2)
20–25
1.0

25–30
0.5

<20 or >30
0

Dietary Vitamin E (mg/day)
>15
1.0

8–15
0.5

<8
0

Plasma pro‐Vitamin A Carotenoids (ng/ml)
>450
1.0

300–450
0.5

<300
0

Plasma Vitamin D (nM)
>80
1.0

65–80
0.5

<65
0

Plasma CRP (mg/L)
<1
1.0

1–3
0.5

>3
0

Plasma α‐Tocopherol (μg/ml)
12–18
1.0

>18
0.5

<12
0

Association of HI score with mortality and hyper‐γT. Subjects were assigned composite HI scores based on Table 1. Odds ratios for all‐cause mortality and hyper‐γT as categorical variables were determined for each stratified group (<2; 2.5‐3; 3.5–4; 4.5; 5; >5.5).

Mean HI Score
Subjects (N)
Deaths (N)
Hyper‐γ‐T (N)
Mortality (OR)
p Value
Hyper‐γ‐T (OR)
p value

1.60
57
12
37
7.00
0.0008
6.92
<0.0001

2.78
117
12
65
3.00
0.069
4.68
<0.0001

3.77
182
10
77
1.53
NS
2.74
0.0002

4.50
87
1
27
0.31
NS
1.68
NS

5.00
85
3
20
0.96
NS
1.15
NS

5.86
109
4
23
1.0 (Ref)
‐
1.0 (Ref)
‐